Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TM4SF1 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Tm4sf1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TM4SF1 mRNA | CTD | PMID:36331819 | 1,1-dichloroethene | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of TM4SF1 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | multiple interactions | ISO | Tm4sf1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TM4SF1 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of TM4SF1 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of TM4SF1 mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of TM4SF1 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of TM4SF1 mRNA more ... | CTD | PMID:24758408 more ... | 17beta-estradiol | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of TM4SF1 mRNA | CTD | PMID:19167446 more ... | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of TM4SF1 mRNA | CTD | PMID:29581250 | 2,2',5,5'-tetrachlorobiphenyl | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:36804509 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TM4SF1 mRNA | CTD | PMID:21802500 and PMID:30096437 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TM4SF1 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TM4SF1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TM4SF1 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TM4SF1 mRNA | CTD | PMID:12377990 and PMID:26238291 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TM4SF1 mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TM4SF1 mRNA | CTD | PMID:21570461 | 2,4-diaminotoluene | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | 2 and 4-diaminotoluene results in increased expression of TM4SF1 mRNA | CTD | PMID:20713471 | 2-butoxyethanol | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of TM4SF1 mRNA | CTD | PMID:19812364 | 2-hydroxypropanoic acid | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of TM4SF1 mRNA | CTD | PMID:30851411 | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of TM4SF1 mRNA | CTD | PMID:28522335 | 3-methylcholanthrene | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of TM4SF1 mRNA | CTD | PMID:20713471 | 4,4'-sulfonyldiphenol | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of TM4SF1 mRNA | CTD | PMID:30951980 | 4-hydroxyphenyl retinamide | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of TM4SF1 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of TM4SF1 mRNA | CTD | PMID:24780913 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of TM4SF1 mRNA | CTD | PMID:28959563 | afimoxifene | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | afimoxifene inhibits the reaction [Estrogens results in decreased expression of TM4SF1 mRNA] | CTD | PMID:21233418 | aflatoxin B1 | affects expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of TM4SF1 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of TM4SF1 mRNA | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of TM4SF1 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Tretinoin results in increased expression of TM4SF1 mRNA | CTD | PMID:37278767 | antirheumatic drug | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of TM4SF1 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of TM4SF1 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | Fulvestrant inhibits the reaction [arsenite results in decreased expression of TM4SF1 mRNA] | CTD | PMID:31646340 | arsenite(3-) | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | arsenite results in decreased expression of TM4SF1 mRNA | CTD | PMID:31646340 | arsenous acid | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of TM4SF1 mRNA | CTD | PMID:22521957 | arsenous acid | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of TM4SF1 mRNA | CTD | PMID:20458559 | benzo[a]pyrene | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of TM4SF1 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases methylation | ISO | TM4SF1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of TM4SF1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of TM4SF1 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of TM4SF1 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of TM4SF1 mRNA | CTD | PMID:21802500 | beta-naphthoflavone | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of TM4SF1 mRNA | CTD | PMID:32858204 | bexarotene | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | bexarotene results in increased expression of TM4SF1 mRNA | CTD | PMID:17178900 | bis(2-ethylhexyl) phthalate | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of TM4SF1 mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TM4SF1 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of TM4SF1 mRNA | CTD | PMID:30951980 and PMID:32156529 | bisphenol A | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of TM4SF1 mRNA | CTD | PMID:29275510 | bisphenol A | affects expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of TM4SF1 mRNA | CTD | PMID:30903817 | bisphenol A | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of TM4SF1 mRNA | CTD | PMID:27685785 | bisphenol F | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of TM4SF1 mRNA | CTD | PMID:30951980 | cadmium atom | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Cadmium results in decreased expression of TM4SF1 mRNA | CTD | PMID:16439709 more ... | cadmium atom | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | Fulvestrant inhibits the reaction [Cadmium results in decreased expression of TM4SF1 mRNA] | CTD | PMID:31646340 | cadmium atom | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Cadmium results in increased expression of TM4SF1 mRNA | CTD | PMID:23369406 | cadmium dichloride | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TM4SF1 mRNA | CTD | PMID:12634122 | calcitriol | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of TM4SF1 mRNA | CTD | PMID:21592394 | calcitriol | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of TM4SF1 mRNA | CTD | PMID:26485663 | calcitriol | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of TM4SF1 mRNA | CTD | PMID:16002434 and PMID:21592394 | carbamazepine | affects expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of TM4SF1 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of TM4SF1 mRNA | CTD | PMID:25554681 | carbon nanotube | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of TM4SF1 mRNA | CTD | PMID:25620056 | CGP 52608 | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to TM4SF1 gene] | CTD | PMID:28238834 | chloropicrin | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | chloropicrin results in increased expression of TM4SF1 mRNA | CTD | PMID:26352163 | chromium(6+) | affects expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of TM4SF1 mRNA | CTD | PMID:28472532 | coumestrol | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA | CTD | PMID:19167446 | crocidolite asbestos | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in increased expression of TM4SF1 mRNA | CTD | PMID:25351596 | crocidolite asbestos | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased expression of TM4SF1 mRNA | CTD | PMID:29523930 | cyclophosphamide | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Cyclophosphamide results in increased expression of TM4SF1 mRNA | CTD | PMID:17403535 | cyclosporin A | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of TM4SF1 mRNA | CTD | PMID:19770486 | cyclosporin A | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of TM4SF1 mRNA | CTD | PMID:19159671 more ... | diarsenic trioxide | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of TM4SF1 mRNA | CTD | PMID:20458559 | diarsenic trioxide | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of TM4SF1 mRNA | CTD | PMID:22521957 | dibutyl phthalate | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of TM4SF1 mRNA | CTD | PMID:21266533 | dichromium trioxide | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TM4SF1 mRNA | CTD | PMID:12634122 | diethyl maleate | increases expression | EXP | | 6480464 | diethyl maleate results in increased expression of TM4SF1 mRNA | CTD | PMID:21161181 | dioxygen | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of TM4SF1 mRNA | CTD | PMID:24236059 | dioxygen | multiple interactions | ISO | Tm4sf1 (Mus musculus) | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of TM4SF1 mRNA | CTD | PMID:19640911 | dorsomorphin | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM4SF1 mRNA | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of TM4SF1 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA | CTD | PMID:19167446 | epoxiconazole | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of TM4SF1 mRNA | CTD | PMID:35436446 | ethylparaben | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | ethyl-p-hydroxybenzoate results in increased expression of TM4SF1 mRNA | CTD | PMID:37690743 | folic acid | affects expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Folic Acid affects the expression of TM4SF1 mRNA | CTD | PMID:17320366 | folic acid | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of TM4SF1 mRNA | CTD | PMID:21867686 | folic acid | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of TM4SF1 mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | ISO | Tm4sf1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TM4SF1 mRNA | CTD | PMID:22206623 | fulvestrant | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | Fulvestrant inhibits the reaction [arsenite results in decreased expression of TM4SF1 mRNA] more ... | CTD | PMID:31646340 | fulvestrant | increases methylation | ISO | TM4SF1 (Homo sapiens) | 6480464 | Fulvestrant results in increased methylation of TM4SF1 gene | CTD | PMID:31601247 | fulvestrant | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Fulvestrant results in increased expression of TM4SF1 mRNA | CTD | PMID:31646340 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of TM4SF1 mRNA | CTD | PMID:27387713 | gold atom | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Gold results in increased expression of TM4SF1 mRNA | CTD | PMID:29705079 | gold(0) | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Gold results in increased expression of TM4SF1 mRNA | CTD | PMID:29705079 | isoflavones | affects expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Isoflavones affects the expression of TM4SF1 mRNA | CTD | PMID:16365062 | isoflavones | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Isoflavones results in decreased expression of TM4SF1 mRNA | CTD | PMID:17374662 | ivermectin | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Ivermectin results in increased expression of TM4SF1 protein | CTD | PMID:32959892 | L-ascorbic acid | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in increased expression of TM4SF1 mRNA | CTD | PMID:17639512 | lead diacetate | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TM4SF1 mRNA | CTD | PMID:12634122 | leflunomide | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | leflunomide results in increased expression of TM4SF1 mRNA | CTD | PMID:28988120 | lipopolysaccharide | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of TM4SF1 mRNA | CTD | PMID:35877022 | lithium chloride | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Lithium Chloride results in increased expression of TM4SF1 mRNA | CTD | PMID:15711924 | methylisothiazolinone | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of TM4SF1 mRNA | CTD | PMID:31629900 | methylmercury chloride | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of TM4SF1 mRNA | CTD | PMID:28001369 | methylparaben | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | methylparaben results in decreased expression of TM4SF1 mRNA | CTD | PMID:31745603 | Monobutylphthalate | decreases expression | EXP | | 6480464 | monobutyl phthalate results in decreased expression of TM4SF1 mRNA | CTD | PMID:29162477 | nickel sulfate | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of TM4SF1 mRNA | CTD | PMID:22714537 | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of TM4SF1 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of TM4SF1 mRNA | CTD | PMID:25729387 | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of TM4SF1 mRNA | CTD | PMID:31397875 | paracetamol | affects expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of TM4SF1 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of TM4SF1 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of TM4SF1 mRNA | CTD | PMID:22230336 and PMID:29067470 | paracetamol | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of TM4SF1 mRNA | CTD | PMID:11264010 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of TM4SF1 mRNA | CTD | PMID:32680482 | pentachlorophenol | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Pentachlorophenol results in decreased expression of TM4SF1 mRNA | CTD | PMID:23892564 | perfluorohexanesulfonic acid | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of TM4SF1 mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Tm4sf1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TM4SF1 mRNA | CTD | PMID:36331819 | phenylmercury acetate | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of TM4SF1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM4SF1 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TM4SF1 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of TM4SF1 mRNA | CTD | PMID:18301758 and PMID:23811191 | pirinixic acid | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of TM4SF1 mRNA | CTD | PMID:18445702 | piroxicam | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Piroxicam results in decreased expression of TM4SF1 mRNA | CTD | PMID:21858171 | potassium chromate | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of TM4SF1 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TM4SF1 mRNA | CTD | PMID:22079256 | quercetin | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in increased expression of TM4SF1 mRNA | CTD | PMID:17639512 | quercetin | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Quercetin results in increased expression of TM4SF1 mRNA | CTD | PMID:21632981 | rac-lactic acid | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of TM4SF1 mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM4SF1 mRNA | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of TM4SF1 mRNA and Silicon Dioxide results in increased expression of TM4SF1 mRNA | CTD | PMID:25351596 and PMID:25895662 | silver atom | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Silver results in decreased expression of TM4SF1 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Silver results in decreased expression of TM4SF1 mRNA | CTD | PMID:27131904 | sodium arsenite | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TM4SF1 mRNA | CTD | PMID:12634122 | sodium arsenite | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of TM4SF1 mRNA | CTD | PMID:12377979 | sodium arsenite | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of TM4SF1 mRNA | CTD | PMID:12634122 | sodium dodecyl sulfate | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of TM4SF1 mRNA | CTD | PMID:31734321 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of TM4SF1 mRNA | CTD | PMID:19281266 | sunitinib | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of TM4SF1 mRNA | CTD | PMID:31533062 | tamoxifen | affects expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Tamoxifen affects the expression of TM4SF1 mRNA | CTD | PMID:14699072 | tamoxifen | affects expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of TM4SF1 mRNA | CTD | PMID:17555576 | tert-butyl hydroperoxide | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of TM4SF1 mRNA | CTD | PMID:12766906 and PMID:15336504 | testosterone | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of TM4SF1 mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | ISO | TM4SF1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of TM4SF1 mRNA | CTD | PMID:21592394 | tetrachloromethane | affects expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of TM4SF1 mRNA | CTD | PMID:17484886 | tetrachloromethane | decreases expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of TM4SF1 mRNA | CTD | PMID:31919559 | tetrathiomolybdate(2-) | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | tetrathiomolybdate results in decreased expression of TM4SF1 mRNA | CTD | PMID:37290678 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of TM4SF1 mRNA | CTD | PMID:34492290 | toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of TM4SF1 mRNA | CTD | PMID:22967744 | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of TM4SF1 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of TM4SF1 mRNA | CTD | PMID:25729387 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of TM4SF1 mRNA | CTD | PMID:33387578 | tunicamycin | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of TM4SF1 mRNA | CTD | PMID:33545341 | valproic acid | affects expression | ISO | Tm4sf1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of TM4SF1 mRNA | CTD | PMID:17292431 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of TM4SF1 mRNA | CTD | PMID:29427782 | valproic acid | increases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TM4SF1 mRNA | CTD | PMID:28001369 | valproic acid | decreases expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TM4SF1 mRNA | CTD | PMID:23179753 and PMID:29154799 | valproic acid | affects expression | ISO | TM4SF1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TM4SF1 mRNA | CTD | PMID:25979313 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of TM4SF1 mRNA | CTD | PMID:23034163 | |